Enhancing KDM5A and TLR activity improves the response to immune checkpoint blockade

Journal: Science Translational Medicine

Published: 2020-09-09

DOI: 10.1126/scitranslmed.aax2282

Affiliations: 20

Authors: 23

Go to article
Institutions Share
Department of Computer Science (CS), NJIT, United States of America (USA) 0.13
School of Pharmaceutical Sciences, Tsinghua, China 0.11
MOE Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, Tsinghua, China 0.11
Advanced Innovation Center for Human Brain Protection, Capital Medical University, China 0.11
Department of Chemistry and Biochemistry, UC San Diego, United States of America (USA) 0.09
Lanzhou Institute of Husbandry and Pharmaceutical Sciences (LIHPS), CAAS, China 0.04
Department of Medicine, Pitt, United States of America (USA) 0.04
MOE Key Laboratory of Bioinformatics, Tsinghua, China 0.04
School of Medicine, Tsinghua, China 0.04
Institute for Immunology, Tsinghua, China 0.04
Basic Medical College, CDUTCM, China 0.04
Beijing Advanced Innovation Center for Genomics (ICG), PKU, China 0.03
Center for Life Sciences (CLS), PKU, China 0.03
Biomedical Pioneering Innovation Center (BIOPIC), PKU, China 0.03
Duke Division of Neurosurgery, United States of America (USA) 0.02
Preston Robert Tisch Brain Tumor Center at Duke, United States of America (USA) 0.02
Department of Computer Science, UMCP, United States of America (USA) 0.01
Center for Bioinformatics and Computational Biology (CBCB), UMCP, United States of America (USA) 0.01
NIH NCI Center for Cancer Research (CCR), United States of America (USA) 0.01
Beijing Obstetrics and Gynecology Hospital, Capital Medical University, China 0.01